Hepatitis A and E: Clinical sciences

Last updated: January 30, 2025

Hepatitis A and E: Clinical sciences

Watch later

Watch later

Breast cancer: Pathology review
Estrogen and progesterone
Thyroid nodules and thyroid cancer: Pathology review
Cirrhosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Gastrointestinal bleeding: Pathology review
Pancreatitis: Pathology review
Anatomy of the abdominal viscera: Liver, biliary ducts and gallbladder
Anatomy clinical correlates: Other abdominal organs
Anatomy of the abdominal viscera: Pancreas and spleen
Bile secretion and enterohepatic circulation
Liver anatomy and physiology
Pancreatic secretion
Jaundice: Pathology review
Approach to biliary colic: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Acute pancreatitis: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Approach to ascites: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Chronic pancreatitis: Clinical sciences
Diverticulitis: Clinical sciences
Ileus: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Irritable bowel syndrome: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Rectus sheath hematoma: Clinical sciences
Retroperitoneal hematoma: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Femoral hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Breast cyst: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Fibroadenoma: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Breast abscess: Clinical sciences
Mastitis: Clinical sciences
Approach to nipple discharge: Clinical sciences
Breast papilloma: Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Thyroid carcinoma: Clinical sciences
Thyroid nodules: Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Anal cancer: Clinical sciences
Anal fissure: Clinical sciences
Colorectal cancer: Clinical sciences
Hemorrhoids: Clinical sciences
Approach to melena and hematemesis: Clinical sciences
Gastroesophageal varices: Clinical sciences
Mallory-Weiss syndrome: Clinical sciences
Esophageal perforation: Clinical sciences
Stress ulcers: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Pancreatic cancer: Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Hemochromatosis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Pilonidal disease: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to postoperative hypotension: Clinical sciences
Approach to postoperative acute kidney injury: Clinical sciences
Approach to postoperative respiratory distress: Clinical sciences
Approach to postoperative wound complications: Clinical sciences
Pulmonary embolism: Clinical sciences
Surgical site infection: Clinical sciences
Approach to shock: Clinical sciences
Multiple organ dysfunction syndrome (MODS): Clinical sciences
Neurogenic shock: Clinical sciences
Adrenal insufficiency: Clinical sciences
Sepsis: Clinical sciences
Toxic shock syndrome: Clinical sciences
Anaphylaxis: Clinical sciences
Hypovolemic shock: Clinical sciences
Approach to hematochezia: Clinical sciences
Burns: Clinical sciences
Cardiac tamponade: Clinical sciences
Hemothorax: Clinical sciences
Pneumothorax: Clinical sciences
Lipoma: Clinical sciences
Folliculitis, furuncles, and carbuncles: Clinical sciences
Cellulitis and erysipelas: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Skin abscess: Clinical sciences
Approach to skin and soft tissue injury: Clinical sciences
Melanoma: Clinical sciences
Bladder injury: Clinical sciences
Pelvic fractures: Clinical sciences
Compartment syndrome: Clinical sciences
Hypothermia: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Nephrolithiasis: Clinical sciences
Clostridioides difficile infection: Clinical sciences
Approach to constipation: Clinical sciences
Colonic volvulus: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Fecal impaction: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Hepatitis A and E viruses are RNA viruses typically transmitted by the fecal-oral route that infect hepatocytes, causing inflammation of the liver. Acute infection with both viruses usually causes a mild, self-limiting illness, although manifestations can range from asymptomatic infection to severe, life-threatening disease. Hepatitis E can also persist in the body and progress into a chronic infection.

Now, if your patient presents with a chief concern suggesting Hepatitis A or E infection, perform an ABCDE assessment to determine if they are unstable or stable. If the patient is unstable, first stabilize their airway, breathing, and circulation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, and pulse oximetry. Finally, if needed, don’t forget to provide supplemental oxygen!

Now here’s a clinical pearl to keep in mind! In rare cases, acute Hepatitis A or E infection can lead to fulminant hepatic failure, causing an unstable presentation that requires acute management. Patients may present with manifestations of hepatic encephalopathy, like impaired mental status and asterixis; coagulopathy, with INR greater than or equal to 1.5; and elevated AST, ALT, and bilirubin. In addition to stabilization efforts, you should consult the surgical team, since these patients need rapid transfer to a liver transplant center!

Okay, now let’s go back to the ABCDE assessment and focus on stable patients. If your patient is stable, first obtain a focused history and physical examination, and order labs, including CMP, CBC, and INR. History typically reveals symptoms, such as malaise, loss of appetite, nausea, vomiting, and right upper quadrant pain. Your patient will also likely report a risk factor for fecal-oral transmission, such as exposure to contaminated food or water; travel to areas with poor hygiene and sanitation; and direct contact with an infected person.

Next, the physical exam will typically reveal elevated temperature, jaundice, and hepatomegaly, sometimes with tenderness to palpation of the liver. Finally, labs will usually show elevated ALT, AST, and bilirubin. In some individuals, you might even notice elevated INR and thrombocytopenia. With these findings, you should suspect acute Hepatitis A or E infection!

Now, once you suspect hepatitis A or E infection, your next step is to order additional labs to detect the infection. First, you could check whether or not your patient has IgM antibodies against hepatitis A and E viruses, which is the first type of antibody to appear during an acute infection. Alternatively, you could order a reverse-transcriptase polymerase chain reaction, or RT-PCR, to detect viral RNA of hepatitis A and E viruses in the blood.

Okay, now, if both IgM antibody tests and both RT-PCR tests are negative, consider an alternative diagnosis! Remember that several other viruses can present similarly, including hepatitis B, C, and D, as well as cytomegalovirus and Epstein-Barr virus!

On the flip side, if your patient has positive anti-Hepatitis A Virus IgM and positive Hepatitis A Virus RT-PCR, diagnose acute hepatitis A Infection! Hepatitis A infection is generally a self-limited condition, with full clinical recovery and clearance of lab markers within 3 to 6 months. So, in this case, management primarily relies on supportive care with oral or IV fluids, as well as nutritional support. If needed, offer symptomatic treatment with medications for nausea and vomiting.

Next, counsel your patient on lifestyle modifications, such as avoidance of hepatotoxins, including acetaminophen and alcohol. Your patient should also receive the Hepatitis B vaccine series once recovered from acute Hepatitis A infection.

Sources

  1. "Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020 " MMWR Morb Mortal Wkly Rep (2020)
  2. "Hepatitis E Questions and Answers for Health Professionals" cdc
  3. "Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment" World J Gastroenterol (2020)
  4. "EASL Clinical Practice Guidelines on hepatitis E virus infection" J Hepatol (2018)
  5. "Hepatitis A Fact Sheet" World Health Organization (2022)
  6. "Hepatitis E Fact Sheet" World Health Organization (2022)
  7. "Hepatitis A" Am Fam Physician (2021)